Medical News

RSS

New scientific statement urges doctors to prescribe exercise for heart health

Exercise should be prescribed as a foundational component of cardiovascular disease (CVD) prevention and treatment, according to a new American College of Cardiology Scientific Statement published today in JACC, its flagship journal.

15 Oct 2026

Lactation drug cabergoline may reduce breast cancer risk in mothers

An international team of scientists has found that a lactation drug could reduce the risk of breast cancer in mothers after childbirth.

15 Oct 2026

Light-activated experimental opioid eliminates dangerous side effects

Opioid painkillers are some of the strongest analgesic medicines, but they are also the riskiest owing to a range of side effects, including addiction.

15 Oct 2026

Scientists expand global climate scenarios to include public health

About a decade ago, a group of climate scientists described five scenarios for the future. Called the Shared Socioeconomic Pathways (SSPs), these scenarios suggest how socioeconomic development could evolve in worlds with differing challenges to climate adaptation and mitigation.

15 Oct 2026

Parents invent home safety fixes for medically complex children

Approximately 1 in 20 U.S. children younger than 18 years of age are medically complex, meaning they have multiorgan system conditions like cerebral palsy and depend on implanted tube-related medical technology.

15 Oct 2026

Targeting the STING pathway could help prevent osteoporosis

As we age, our bones become weak and brittle, a process called osteoporosis. This bone loss is caused by changes in the cells within the bone marrow microenvironment, such as elevated fat and inflammation-promoting immune cells.

15 Oct 2026

Heart failure alters bone marrow to promote harmful inflammation

Heart failure (HF) alters the bone marrow (BM), reducing protective cells that regulate inflammation, reports a study conducted at Science Tokyo.

15 Oct 2026

Poll: Most older adults rush Medicare choices despite major policy changes

It's one of the biggest decisions they might make all year, affecting their wallets and their healthcare for the full year to come.

15 Oct 2026

A protective brain enzyme may counteract aging-associated cognitive decline

Cinzia Vicidomini, PhD, and Amar Sahay, PhD, of the Mass General Brigham Department of Psychiatry, the Harvard Stem Cell Institute and the Broad Institute of Harvard and MIT, are the lead and senior authors of a paper published in Nature Neuroscience, "An aging-sensitive secreted phospholipase confers neuroprotection and cognitive resilience."

15 Oct 2026

Researchers identify molecular pathway that improves ultrasound-based bone defect healing

Researchers from Capital Medical University, Beijing, China, have identified a CaN/NFATC3/Id3/E2A/Bmp4 signaling pathway that helps explain how low-intensity pulsed ultrasound (LIPUS) promotes bone regeneration.

15 Oct 2026

New AI project models human behavior to track epidemic spread

A consortium led by the University de Zaragoza, with the participation of Universidad Carlos III de Madrid (UC3M), has been selected in the 2026 Health Research Call by the "la Caixa" Foundation—one of the most competitive biomedical research funding calls in Spain and Portugal.

15 Oct 2026

New study reveals how Candida auris evades antifungal drugs

New research has revealed an unexpected new mechanism through which the killer fungus Candida auris is resisting antifungal drug treatment.

15 Oct 2026

INmune Bio Inc. and Quantum Computing Inc. partner to apply quantum optimization and AI to advance Alzheimer’s drug research and explore new applications for XPro

INmune Bio Inc. and Quantum Computing Inc. today announced a collaboration to apply quantum computing, artificial intelligence (AI) and data analytics to identify new potential applications for XPro (XPro1595), INmune Bio's investigational treatment for Alzheimer's disease and other disease conditions.

From INmune Bio 15 Oct 2026

Leading life science organizations collaborate for second London Bio-Innovation Week

One Nucleus, The Society for Laboratory Automation and Screening (SLAS), and ELRIG today announced that they will be collaborating during the second London Bio-Innovation Week, to facilitate multi-event and community networking and partnering opportunities for life science companies, academic researchers, bio-entrepreneurs, investors and advisers.

From Society for Laboratory Automation and Screening (SLAS) 15 Oct 2026

AI detects daily stress by analyzing routine smartphone behaviors

Clues to stress can be hidden in everyday habits such as chatting, searching, and making payments on a smartphone.

14 Oct 2026

Global study exposes gaps in global endometriosis care guidelines

Adolescents, gender-diverse people and those with lived experience are underrepresented in endometriosis guidelines worldwide, a University of Queensland study has found.

14 Oct 2026

Coffee drinkers had fewer repeat blood clots in a Norwegian study

A Norwegian study involving 2,071 patients found that those who reported drinking 1 to 2 cups of coffee daily before their first venous thromboembolism had a 51% lower estimated risk of recurrence than non-drinkers. The association was strongest among patients whose initial blood clot was provoked, although the observational study could not establish that coffee consumption prevents recurrence.

14 Oct 2026

Rapid growth in private testosterone prescribing raises safety concerns

The rapid expansion of private testosterone prescribing risks extending treatment beyond men with clearly defined need to people with non-specific symptoms and borderline test results, for whom the balance of benefit and long term risk are less certain, warn experts in The BMJ today.

14 Oct 2026

Experts call for lifelong care after brain and spinal injuries

In a new paper published in The Lancet Neurology, "Reframing traumatic brain injury and spinal cord injury as chronic multisystem disorders: toward integrated, long-term care," international experts across institutions and disciplines propose a fundamental shift in how traumatic brain and spinal cord injuries in adults are understood and managed. Sandro Marini, MD, of the Mass General Brigham Neuroscience Institute, is a co-first author, and Saef Izzy, MD, also of the Neuroscience Institute, is one of the co-senior authors, and the primary corresponding author.

14 Oct 2026

Bulk adverse event reporting may delay medical device safety warnings

Permitting medical device manufacturers to submit bulk summary reports of adverse events to the US Food and Drug Administration (FDA), rather than reporting individual cases, often fails to promptly detect potential safety signals, finds a study published by The BMJ today.

14 Oct 2026